about
A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell RecognitionImpact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation conditionCrystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3.A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen.Cross-reactive anti-viral T cells increase prior to an episode of viral reactivation post human lung transplantation.Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvantDendritic Cell-Mediated Phagocytosis but Not Immune Activation Is Enhanced by PlasminThe Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft RejectionThe activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology.Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasionMaintenance of the EBV-specific CD8+ TCRαβ repertoire in immunosuppressed lung transplant recipients.Deciphering the clinical relevance of allo-human leukocyte antigen cross-reactivity in mediating alloimmunity following transplantation.Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions.The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia.Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients.Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells.Differential dynamics of donor DC and non-DC peripheral blood mononuclear cell microchimerism in lung transplantation.Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.Recognition of distinct cross-reactive virus-specific CD8+ T cells reveals a unique TCR signature in a clinical setting.Clara cells and injury post lung transplantation: an evolving story.Safety, feasibility, and effect of remote ischemic conditioning in patients undergoing lung transplantation.Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.A novel cis-AB variant allele arising from a nucleotide substitution A796C in the B transferase gene.Exhaled Breath Condensate Pepsin: Potential Noninvasive Test for Gastroesophageal Reflux in COPD and Bronchiectasis.Identification of Native and Post-Translationally Modified HLA-B*57:01-Restricted HIV Envelope Derived Epitopes Using Immunoproteomics.Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug HypersensitivityInability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common VirusesA subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligandsHLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidomeNatural Killer Cell Activation in the Lung Allograft Early PosttransplantationUse of the polymerase chain reaction-sequence specific oligonucleotide technique for the detection of the K1/K2 polymorphism of the Kell blood group systemExpression of surfactant protein mRNA in normal and neoplastic lung of B6C3F1 mice as demonstrated by in situ hybridizationHigh levels of mannose-binding lectin are associated with poor outcomes after lung transplantationHuman CD8+ T cell cross-reactivity across influenza A, B and C virusesInfluenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading FramesHLA-associated antiepileptic drug-induced cutaneous adverse reactionsResponse to Comment on "A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands"
P50
Q27641906-BB8CB222-A95A-4A00-A30D-A3C2A438BC55Q28488660-68919E32-90DC-49C8-926A-DE721498D32AQ34336817-429EDE3B-F274-4E53-992B-5AFAEE884183Q34412732-B93691EE-21D8-4EAB-8B2E-97B844B6EE87Q34584683-AFEA7AA4-7787-4AF8-A8A3-94D0EDFC7675Q35319290-E5A022C3-8900-4874-B56C-B338D099F932Q35680210-0F94482D-5E48-4F7C-B38E-2A96FA242A1DQ35753770-20E3A9A7-687D-47F8-918E-F5C5A5125A82Q35830783-AEFCD4D7-B769-4423-9471-92C88F13CF60Q36403929-934464C4-F2B7-43E1-BDD9-95D2B4AA0939Q37559771-FB2BE460-931C-4A17-B1CB-301D550B03E3Q38635492-E61EFDE7-FF1C-4189-BC92-0F87B0BC3C37Q38854309-02FF30B9-AFB0-45AA-9AFA-8F972DC9B729Q38951695-68BC2D92-A65F-416B-9C35-BFF37E1B1624Q39637183-1027235F-885A-4B2F-8547-2559BF2C6F33Q39895985-D65562F0-078B-4962-82DD-555859610F7AQ39953678-DD161F5A-F596-44CD-A3B2-DF12432D0C23Q40284441-A8D5F68D-3A56-4EEC-819C-55D9E767D8FDQ42221631-DAF1DEF0-FC55-4839-8603-0E1678274527Q43454310-32425005-0246-421E-B1B2-9E8BF68714CFQ44786679-3296EBA4-204A-461C-937C-DDB006EA2B72Q44831120-BC70FF48-F80E-48A5-BC46-03E1666A912BQ47817863-221468B2-E46C-4478-9E1E-E12EB6B358C8Q48019876-91131D1C-654F-46B3-83D7-5C10F3CC533CQ50045443-ECD36BCE-F616-408E-8229-0D5375151D73Q56917070-62DB9F61-ED5D-49D0-92E2-552E7B905345Q57221787-3DAA44BE-1DA7-4B63-AEC4-EF3BE12367A3Q57820355-B1BEEB9F-730E-4366-9935-7AE4C2B92166Q58586444-CAD40F9B-0251-4A5F-91DA-22B329C7436DQ62651473-77F2F9C6-6453-48F4-82A4-F0D7DEDCAC89Q73436873-A861419E-B9FF-4885-9640-5335501595DEQ77916036-20DF2001-DE94-40BD-B542-A2F61E161ECCQ83586186-0B95C446-F0E0-4D8B-80B8-BB2C3C3D39A2Q91692073-41C6C15E-AC14-4A2F-914A-1C9D197C0473Q92050459-F6D51962-5DF4-4FF3-A74A-975871F7D323Q92518464-5365237F-6CC5-474F-BDEE-0CF721F37E0AQ92667301-0D9A87CD-D54A-4E5F-868A-21FEC4087A77
P50
description
researcher ORCID id 0000-0001-8647-2102
@en
wetenschapper
@nl
name
Nicole A Mifsud
@ast
Nicole A Mifsud
@en
Nicole A Mifsud
@es
Nicole A Mifsud
@nl
type
label
Nicole A Mifsud
@ast
Nicole A Mifsud
@en
Nicole A Mifsud
@es
Nicole A Mifsud
@nl
prefLabel
Nicole A Mifsud
@ast
Nicole A Mifsud
@en
Nicole A Mifsud
@es
Nicole A Mifsud
@nl
P106
P1153
6603182406
P21
P31
P496
0000-0001-8647-2102